CoreWeave Bloodbath: Can You Survive the Plunge Below $100?

xc__
08-14

$CoreWeave, Inc.(CRWV)$ The tech world is reeling as CoreWeave’s stock faces a brutal pullback after its latest earnings report on August 13, 2025, revealed a revenue surge to $1.21 billion—up from $395 million year-over-year, beating estimates with OpenAI’s support. Yet, the operating margin cratered from 20% to 2%, sparking profit-taking and a sharp drop, with shares sliding 13.44% to $128.76 in premarket trading. Against a backdrop of a robust S&P 500 at 6,297.36 and Nasdaq at 20,884.27, fueled by crypto gains (Bitcoin at $121,000), tariffs (30% on EU/Mexico, 35% on Canada) and oil at $75/barrel add pressure. Is CoreWeave’s growth momentum enough to offset margin woes? Could this drop be a healthy correction after a 147% rally, or will it crash below $100? This analysis explores the earnings fallout, market dynamics, and strategies to navigate this volatile dip.

Earnings Fallout: Growth vs. Margin Pain

CoreWeave’s Q2 2025 revenue jumped 210.3% year-over-year to $1.21 billion, driven by AI demand and partnerships with OpenAI, Microsoft, and its exclusive Blackwell GPU lineup from NVIDIA. Key highlights:

  • Revenue Drivers: OpenAI’s $500 million contract and hyperscaler demand pushed revenue past the $1 billion mark, with Q3 guidance raised to $1.3-$1.4 billion.

  • Margin Collapse: Operating margin shrank to 2% from 20%, with adjusted net loss widening to $0.83 per share (versus $0.16 expected), reflecting heavy AI infrastructure spending.

  • Balance Sheet: Total assets rose $8.4 billion to $15.2 billion, outpacing a $6 billion liability increase, keeping debt leverage at 2.8x equity.

  • Outlook: Management projects triple-digit growth into 2026, but profitability remains elusive until late 2026.

The margin squeeze stems from $1.5 billion in capital expenditures for data centers, a 600 basis point operating margin contraction, and a 37% rise in long-term debt to $4.8 billion. Posts on X suggest investor frustration with the “debt-fueled growth story,” but optimism persists around AI demand.

Market Dynamics: Correction or Collapse?

CoreWeave’s stock, up 147% over the past month to a high of $187, has pulled back to $128.76, testing the 30-day EMA at $125. Analysts see a mixed bag:

  • Correction Case: The 13.44% premarket drop aligns with profit-taking after a parabolic run, with RSI at 55 suggesting room for stabilization. Support at $125 and resistance at $147 indicate a potential $110-$130 range.

  • Collapse Risk: If selling accelerates, the stock could test $100, a psychological level near the 50-day moving average ($120.49), especially with a $9 billion Core Scientific acquisition looming and lockup expirations in August adding 290 million shares.

  • Sector Context: NVIDIA’s $141.20 price and AMD’s $174.50 reflect AI chip strength, but tariff uncertainties and a VIX at 15.94 signal broader volatility. The Nasdaq’s 20,884.27 high offers a bullish tailwind, yet August’s historical 7-10% pullback risk looms.

It seems plausible that the drop is a correction, but a slide below $100 could occur if margin concerns or acquisition doubts intensify, though growth momentum may cap the downside.

Can Growth Outweigh Margin Woes?

CoreWeave’s 210.3% revenue growth and $500 billion AI infrastructure pipeline suggest long-term potential, but shrinking margins raise red flags:

  • Growth Upside: OpenAI’s expanded workloads and NVIDIA’s Blackwell rollout could drive $2 billion in 2026 revenue, with analysts forecasting a 500% annualized growth rate.

  • Margin Challenges: The 2% margin reflects $1 billion in annual capex, with debt servicing at 9.5% rates eating into cash flow. Profitability hinges on scaling efficiency, unlikely before 2027.

  • Competitive Edge: Exclusive GPU access and 250,000 NVIDIA units give CoreWeave a lead over AWS and Google Cloud, but AMD’s MI450 and NVIDIA’s Rubin delay could shift dynamics.

Growth could offset margins if capex yields higher utilization (currently 85%), but a $236 million Q2 net loss forecast signals short-term pain, making the stock a high-risk bet.

Trading and Investment Strategies

Short-Term Plays

  • Buy on Dip: Enter at $120-$125, target $140-$150, stop at $115. A 12-20% gain if correction stabilizes.

  • Buy Below $100: Grab at $95-$100, target $120-$130, stop at $90. A 20-30% gain if oversold conditions trigger a rebound.

  • Options Straddle: Buy $128 calls/puts (August expiry) for volatility, targeting 200-300% gains on a 10%+ move.

  • Scalp Recovery: Buy at $125-$130, sell at $135-$140, stop at $120. A 5-10% gain on sentiment shift.

Long-Term Investments

  • Hold CRWV: Buy at $120-$125, target $180-$200 by 2026, for 40-60% upside with AI growth. Stop at $95.

  • Diversify with SMH ETF: Buy at $280, target $320, stop at $270, for semiconductor exposure.

  • Hold NVDA: Buy at $135-$140, target $180-$200 by 2026, for 30-45% upside with GPU synergy.

  • Defensive Play: Buy Walmart (WMT) at $75-$77, target $85-$90, for 10-17% upside with stability.

Hedge Strategies

  • VIXY ETF: Buy at $15, target $18, stop at $13, to hedge volatility or lockup sell-off.

  • SPY ETF Puts: Use puts at $614 to protect against a 5-10% market pullback.

  • Gold ETF (GLD): Buy at $200, target $220, stop at $190, as a safe-haven hedge.

My Trading Plan

I’m cautiously optimistic, seeing $140-$150 as a near-term target if growth momentum holds. I’ll buy CRWV at $120-$125, targeting $140-$150, with a $115 stop, and add NVDA at $135-$140, targeting $150-$160, with a $130 stop. I’ll use a $128 call/put straddle for volatility. For diversification, I’ll add SMH at $280, targeting $300, with a $270 stop, and WMT at $75-$77, targeting $85, with a $72 stop. I’m hedging with VIXY at $15, targeting $18, and keeping 20% cash for dips if margins or acquisition news worsens. I’ll watch lockup expirations and OpenAI updates.

Key Metrics

The Bigger Picture

CoreWeave’s $1.21 billion revenue beat on August 13, 2025, showcases AI-driven growth, but a 2% margin and $0.83 loss triggered a 13.44% drop to $128.76, testing $125 support. The 147% rally’s correction could stabilize at $110-$130, though a $100 breach is possible if lockup sales or margin fears escalate. OpenAI’s backing and NVIDIA synergy offer upside to $180-$200 by 2026, but profitability delays and tariffs pose risks. Investors should buy on dips below $125, use options for volatility, and hedge with VIXY or GLD. This bloodbath could be a buying opportunity—act decisively.

Will you dive in if CoreWeave hits $100? Share your move below! 🎁

📢 Like, repost, and follow for daily updates on market trends and stock insights.

📝 Disclaimer: This post is for informational purposes only and does not constitute financial advice. Always conduct your own research before making investment decisions.

📌@Daily_Discussion @Tiger_comments @TigerStars @TigerEvents @TigerWire

CoreWeave Below $100?! Oversold on Lock-up Expiration?
CoreWeave will face its first major post-IPO share unlock on Friday, with approximately 84% of its Class A shares becoming tradable. These shares are primarily held by company insiders and key supplier Nvidia. The large influx of shares into the market could trigger further selling pressure. The stock fell below $100 yesterday and rebounded a little in the overnight trading. Questions: Is it oversold on lock-up expiration news? Is it a buy under $100?
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment
1